Search Videos and More
Preparing for the Routine and Unforeseen in the Urologic OR
From 11 am to 11 pm, Joon Park, MSHI, BSN, RN, CNOR, Fox Chase Cancer Center Perioperative Evening Charge Nurse, manages the surgical staff workflow and patient assignments for the Fox Chase Cancer operating room.Fox Chase Fellows Shape the World of Cancer Care
Wherever they go, Fox Chase Fellows and residents bring a significant contribution to the world of cancer care, from distinguished JAMA peer reviews to notable advances in the field of neuroendocrine cancer to accolades for research, academy leadership, and compassionate clinical care.Unconventional and Exceptional: Dr. Lee’s Fox Chase Residency
Peter L. Lee, MD, PhD, has two distinct and interesting roles in radiation oncology at the Mass General Brigham Cancer Institute: one as radiation oncologist specializing in GU cancers, and another as a leader tasked to develop the hospital’s Exercise Oncology Program –a rapidly growing specialty that focuses on the benefits of exercise for cancer management.Defeating Cancer Means Never Resting on Our Laurels
At Fox Chase Cancer Center, our faculty, fellows, and residents always look to the future to develop and collaborate on therapeutic breakthroughs to enhance life and extend it—never resting on accolades earned in the past.Temple Health Appoints Alex Khariton, MBA, as Chief Operating Officer of Fox Chase Cancer Center
Fox Chase Cancer Center (Fox Chase) and Temple Health today announced that Alex Khariton, MBA, has been appointed Chief Operating Officer of Fox Chase and Senior Vice President for Cancer Services across Temple Health effective February 23, 2026.Comprehensive Urology Care for Advanced Practice Providers:
Mastering Inpatient and Outpatient Management
Study Finds Radiation Therapy Administered Before Surgery Rarely Shrinks Retroperitoneal Sarcoma Tumors
According to new research from Fox Chase Cancer Center, radiation therapy administered before surgery rarely produces favorable responses in patients with retroperitoneal sarcoma (RPS), a rare and aggressive cancer that forms in the abdomen. The study reinforces findings from a major international clinical trial and suggests that, due to ineffectiveness, radiation should not be used to shrink tumors before surgery.Home-Based Monitoring Could Transform Care for Patients Receiving T-Cell Redirecting Therapies
A study found that outpatient observation cut hospital stays dramatically, with no adverse safety events reported. It also freed up inpatient beds and cut healthcare costs.A Routine Blood Test Could Help Predict Who Benefits Most from CAR T-Cell Therapy
A study found that measuring a patient’s absolute lymphocyte count can predict how well they’ll respond to the therapy for non-Hodgkin lymphoma. It could offer a practical tool for guiding treatment decisions.2025 Practice-Changing Updates in Bladder, Kidney & Prostate Cancer
Updates in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Matthew Zibelman, MD, Associate Professor, Department of Hematology/Oncology and Director of Clinical and Translational Research for the GU Service Line at Fox Chase Cancer Center discusses the latest optimal therapies and strategies for managing mCRPC.Evolving Evidence in Radiation Oncology


